Miami, FL, United States of America

Noven Therapeutics, LLC


USPTO Granted Patents = 6

% Expired Patents = 16.7


Trademarks = 12

Forward Citations = 8

Loading Chart...
Loading Chart...

11 inventors (with patents filed for the assignee):

goldMedal Patricia Allison Tewes Richards (4 out of 4 patents)

silverMedal Yonglai Yang (1 out of 6 patents)

bronzeMedal Stephan D Parent (1 out of 52 patents)

4.  Frans Van Dalen (1 out of 11 patents)

5.  Travis Houston (1 out of 2 patents)

6.  Bruce Charles Friedman (1 out of 1 patent)

7.  Franciscus Bernardus Gemma Benneker (1 out of 2 patents)

8.  Jacobus Maria Lemmens (1 out of 21 patents)

9.  Theodorus Hendricus Antonium Peters (1 out of 2 patents)

10.  Frantisek Picha (1 out of 18 patents)

11.  David Alan Engers (1 out of 10 patents)

12.  Patricia Allison Richards (0 patent)


6 patents:

Company Overview
Noven Therapeutics, LLC is a specialty pharmaceutical company focused on developing and commercializing innovative therapies for patients with unmet medical needs. With expertise in transdermal drug delivery, Noven is known for its products in areas such as neurology, psychiatry, and women's health. The company is committed to improving patient outcomes through research, development, and commercialization of novel therapeutic options.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

6 Patents

#142 in Miami, FL

#1,451 in Florida

#45,007 in US

Miami, FL (US)
Miami, FL, United States of America
Forward Citations = 8

11 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Noven Therapeutics, LLC. Retrieved from https://idiyas.com/company/noven-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…